Search

Byline: Amanda Sullender Aug. 29Those at risk of a severe allergic reaction always have handy an EpiPen just in case. But soon their life might be saved by a spray [...]

Byline: Amanda Sullender Aug. 26Those at risk of a severe allergic reaction always have handy an EpiPen just in case. But soon their life might be saved by a spray [...]

AUSTIN, Texas -- CDISC is proud to announce a research collaboration with the U.S. Food and Drug Administration's Office of Translational Sciences in the Center for Drug Evaluation and Research [...]

ENPNewswire-May 17, 2023--Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors (C)2023 ENPublishing - http://www.enpublishing.co.uk Release date- 16052023 - DUBLIN - Prothena Corporation plc (NASDAQ: PRTA), a [...]

DUBLIN -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced today the appointment of Billy Dunn, [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): Work for the FDA's Center for Drug Evaluation and Research (CDER) What do [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Joanne S. Eglovitch The FDA Center for Drug Evaluation and Research (CDER) and the Center [...]

CHICAGO, IL -- The following information was released by the American Medical Association (AMA): Featured topic and speakers Experts from the AMA, FDA and CDC discuss tecovirimat, or TPOXX, for [...]

NEW YORK: Mind Medicine (MindMed) Inc. has issued the following news release: Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the 'Company'), a leading biotech company developing psychedelic-inspired [...]

NEW YORK, Dec. 9, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the 'Company'), a leading biotech company developing psychedelic-inspired therapies recently met with the [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Mary Ellen Schneider Dose selection is a significant challenge in pediatric drug development; commonly used [...]

(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements This report contains forward-looking statements within the meaning of Section [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Joanne S. Eglovitch A top official from the US Food and Drug Administration (FDA) offered [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Joanne S. Eglovitch FDA's Patrizia Cavazzoni, Michael Kopcha The US Food and Drug Administration's (FDA'S) [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): FDA's Center for Drug Evaluation and Research's (CDER) Office of New Drugs (OND) [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): Date: November 18 - 19, 2021 Day1: Thu, Nov 18 9:00 AM - [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Joanne S. Eglovitch The US Food and Drug Administration's Center for Drug Evaluation and Research [...]

Byline: Beth Snyder Bulik True or false: Pharmaceutical companies are required to send drug ads to the FDA for approval before they're used. It's false--but you'd already know that if [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): Drug Info Rounds is a series of educational videos for health care professionals [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): The Center for Drug Evaluation and Research (CDER) has launched the voluntary Novel [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): Product: Drugs Recipient: 247rxpill.in United States Issuing Office: Center for Drug Evaluation and [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): Date: November 19, 2021 Time: 9:30 AM - 2:30 AM ET The Food [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Jeff Craven The US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research [...]

ENPNewswire-August 27, 2021--BioCryst Appoints Dr. Steven Galson to Board of Directors (C)2021 ENPublishing - http://www.enpublishing.co.uk Release date- 26082021 - RESEARCH TRIANGLE PARK, N.C. - BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) announced that [...]

ENPNewswire-August 18, 2021--American College of Rheumatology Update on Tocilizumab Shortages (C)2021 ENPublishing - http://www.enpublishing.co.uk Release date- 17082021 - ATLANTA - The American College of Rheumatology (ACR) is actively engaged with [...]

Byline: Amirah Al Idrus The FDA is losing a top official as the search for a new commissioner drags on. Ellis Unger, M.D., a cardiologist who led the agency's Office [...]

SAS, the leader in advanced analytics, will extend a 40-year partnership with the US Food and Drug Administration (FDA) to expand its capabilities in natural language processing, artificial intelligence and [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Joanne S. Eglovitch The mammoth online retailer Amazon received an untitled letter from The US [...]

The U.S. Food and Drug Administration (FDA) initiated an independent review of the previously approved drug intended to treat Alzheimers disease, agency director Janet Woodcock confirmed on Friday. In light [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): This guidance provides recommendations on an alternate electronic format for submissions covered under [...]

BOSTON: ConcertAI has issued the following news release: ConcertAI is embarking on a five-year collaborative research program with the U.S. Food and Drug Administration, 'Evaluation of Real-World Outcomes and Safety [...]